Status:
COMPLETED
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.
Eligibility Criteria
Inclusion
- Type2 diabetes
- Criteria of postprandial plasma glucose and HbA1c are met
Exclusion
- Type1 diabetes
- Patients with antidiabetic drugs
- The other exclusion criteria are met
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00213070
Last Update
September 21 2006
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi, Japan
2
Chiba, Japan
3
Fukuoka, Japan
4
Gifu, Japan